Effect of prefrontal cortex inactivation on behavioral and neurochemical abnormalities in rats with excitotoxic lesions of the entorhinal cortex

Synapse

Volumn 61, Issue 6, 2007, Pages 391-400

  Uehara, Takashi ^a   Sumiyoshi, Tomiki ^a   Matsuoka, Tadasu ^a   Itoh, Hiroko ^a   Kurachi, Masayoshi ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Animal model; Dopamine; Entorhinal cortex; Lesions; Limbic; Medial prefrontal cortex; Schizophrenia

Indexed keywords

DOPAMINE; LIDOCAINE; METHAMPHETAMINE; PHOSPHATE; QUINOLINIC ACID;

AMYGDALOID NUCLEUS; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CEREBROSPINAL FLUID; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINERGIC TRANSMISSION; ENTORHINAL CORTEX; EXCITOTOXICITY; LIMBIC CORTEX; LOCOMOTION; MALE; NEUROCHEMISTRY; NEUROPATHOLOGY; NEUROPSYCHIATRY; NEUROTOXICITY; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PREPULSE INHIBITION; PRIORITY JOURNAL; PSYCHOSIS; RAT; TEMPORAL CORTEX;

AMYGDALA; ANESTHETICS, LOCAL; ANIMALS; DENERVATION; DISEASE MODELS, ANIMAL; DOPAMINE; DOPAMINE UPTAKE INHIBITORS; ENTORHINAL CORTEX; LIDOCAINE; LIMBIC SYSTEM; MALE; METHAMPHETAMINE; MOTOR ACTIVITY; NEURAL INHIBITION; NEURAL PATHWAYS; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; QUINOLINIC ACID; RATS; RATS, WISTAR; SCHIZOPHRENIA; SYNAPTIC TRANSMISSION;

EID: 34147145870     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.20383     Document Type: Article

References (58)

1. Andreasen NC, O'Leary DS, Flaum M, Nopoulos P, Watkins GL, Boles Ponto LL, Hichwa RD. 1997. Hypofrontality in schizophrenia: Distributed dysfunctional circuits in neuroleptic-naive patients. Lancet 349:1730-1734.
2. Bogerts B. 1997. The temporolimbic system theory of positive schizophrenic symptoms. Schizophr Bull 23:423-435.
3. Bogerts B, Meertz E, Schonfeldt-Bausch R. 1985. Basal ganglia and limbic system pathology in schizophrenia. A morphometric study of brain volume and shrinkage. Arch Gen Psychiatry 42:784-791.
4. Bogerts B, Ashtari M, Degreef G, Alvir JM, Bilder RM, Lieberman JA. 1990. Reduced temporal limbic structure volumes on magnetic resonance images in first episode schizophrenia. Psychiatry Res 35:1-13.
5. Brinley-Reed M, Mascagni F, McDonald AJ. 1995. Synaptology of prefrontal cortical projections to the basolateral amygdala: An electron microscopic study in the rat. Neurosci Lett 202:45-48.
6. Carlsson A. 1988. The current status of the dopamine hypothesis of schizophrenia. Neuropsychopharmacology i:179-186.
7. Catterall WA. 1980. Neurotoxins that act on voltage-sensitive sodium channels in excitable membranes. Annu Rev Pharmacol Toxicol 20:15-43.
8. Degreef G, Ashtari M, Bogerts B, Bilder RM, Jody DN, Alvir JM, Lieberman JA. 1992. Volumes of ventricular system subdivisions measured from magnetic resonance images in first-episode schizophrenic patients. Arch Gen Psychiatry 49:531-537.
9. Falkai P, Bogerts B, Rozumek M. 1988. Limbic pathology in schizophrenia: The entorhinal region - A morphometric study. Biol Psychiatry 24:515-521.
10. Goto K, Ueki A, Iso H, Morita Y. 2002. Reduced prepulse inhibition in rats with entorhinal cortex lesions. Behav Brain Res 134:201-207.
11. Goto Y, O'Donnell P. 2004. Prefrontal lesion reverses abnormal mesoaccumbens response in an animal model of schizophrenia. Biol Psychiatry 55:172-176.
12. Grace AA. 1991. Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: A hypothesis for the etiology of schizophrenia. Neuroscience 41:1-24.
13. Grace AA. 2000. Gating of information flow within the limbic system and the pathophysiology of schizophrenia. Brain Res Brain Res Rev 31:330-341.
14. Granato A, Santarelli M, Minciacchi D. 1991. Bihemispheric organization of amygdalo-cortical projections in the rat. Neurosci Lett 127:53-56.
15. Harrison PJ. 1999. The neuropathology of schizophrenia. A critical review of the data and their interpretation. Brain 122(Part 4):593-624.
16. Hazlett EA, Buchsbaum MS. 2001. Sensorimotor gating deficits and hypofrontality in schizophrenia. Front Biosci 6:D1069-D1072.
17. Hazlett EA, Buchsbaum MS, Haznedar MM, Singer MB, Germans MK, Schnur DB, Jimenez EA, Buchsbaum BR, Troyer BT. 1998. Prefrontal cortex glucose metabolism and startle eyeblink modification abnormalities in unmedicated schizophrenia patients. Psychophysiology 35:186-198.
18. Howland JG, Taepavarapruk P, Phillips AG. 2002. Glutamate receptor-dependent modulation of dopamine efflux in the nucleus accumbens by basolateral, but not central, nucleus of the amygdala in rats. J Neurosci 22:1137-1145.
19. Jackson ME, Moghaddam B. 2001. Amygdala regulation of nucleus accumbens dopamine output is governed by the prefrontal cortex. J Neurosci 21:676-681.
20. Karreman M, Moghaddam B. 1996. The prefrontal cortex regulates the basal release of dopamine in the limbic striatum: An effect mediated by ventral tegmental area. J Neurochem 66:589-598.
21. Kawasaki Y, Maeda Y, Urata K, Higashima M, Yamaguchi N, Suzuki M, Takashima T, Ide Y. 1993. A quantitative magnetic resonance imaging study of patients with schizophrenia. Eur Arch Psychiatry Clin Neurosci 242:268-272.
22. Kawasaki Y, Suzuki M, Nohara S, Hagino H, Takahashi T, Matsui M, Yamashita I, Chitnis XA, McGuire PK, Seto H, Kurachi M. 2004. Structural brain differences in patients with schizophrenia and schizotypal disorder demonstrated by voxel-based morphometry. Eur Arch Psychiatry Clin Neurosci 254:406-414.
23. Koch M, Schnitzler HU. 1997. The acoustic startle response in rats - Circuits mediating evocation, inhibition and potentiation. Behav Brain Res 89:35-49.
24. Kurachi M. 2003a. Pathogenesis of schizophrenia. I. Symptomatology, cognitive characteristics and brain morphology. Psychiatry Clin Neurosci 57:3-8.
25. Kurachi M. 2003b. Pathogenesis of schizophrenia. II. Temporo-frontal two-step hypothesis. Psychiatry Clin Neurosci 57:9-15.
26. Kurachi M, Sumiyoshi T, Shibata R, Sun Y-J, Uehara T, Tanii Y, Suzuki M. 2000. Changes in limbic dopamine metabolism following quinolinic acid lesions of the left entorhinal cortex in rats. Psychiatry Clin Neurosci 54:83-89.
27. Lawrie SM, Abukmeil SS. 1998. Brain abnormality in schizophrenia. A systematic and quantitative review of volumetric magnetic resonance imaging studies. Br J Psychiatry 172:110-120.
28. Leonetti M, Desvignes C, Bougault I, Souilhac J, Oury-Donat F, Steinberg R. 2006. 2-Chloro-N-[(S)-phenyl [(2S)-piperidin-2-yl] methyl]-3-trifluoromethyl benzamide, monohydrochloride, an inhibitor of the glycine transporter type 1, increases evoked-dopamine release in the rat nucleus accumbens in vivo via an enhanced glutamatergic neurotransmission. Neuroscience 137:555-564.
29. Liddle PF, Friston KJ, Frith CD, Hirsch SR, Jones T, Frackowiak RS. 1992. Patterns of cerebral blood flow in schizophrenia. Br J Psychiatry 160:179-186.
30. Lipska BK, Al-Amin HA, Weinberger DR. 1998. Excitotoxic lesions of the rat medial prefrontal cortex: Effects on abnormal behaviors associated with neonatal hippocampal damage. Neuropsychopharmacology 19:451-464.
31. Lomber SG. 1999. The advantages and limitations of permanent or reversible deactivation techniques in the assessment of neural function. J Neurosci Methods 86:109-117.
32. McDonald AJ. 1998. Cortical pathways to the mammalian amygdala. Prog Neurobiol 55:257-332.
33. Murase S, Grenhoff J, Chouvet G, Gonon FG, Svensson TH. 1993. Prefrontal cortex regulates burst firing and transmitter release in rat mesolimbic dopamine neurons studied in vivo. Neurosci Lett 157:53-56.
34. Paxinos G, Watson C. 1998. The rat brain in stereotaxic coordinates. Sydney: Academic Press.
35. Roberts GW. 1991. Schizophrenia: A neuropathological perspective. Br J Psychiatry 158:8-17.
36. Seeman P, Schwarz J, Chen JF, Szechtman H, Perreault M, McKnight GS, Roder JC, Quirion R, Boksa P, Srivastava LK, Yanai K, Weinshenker D, Sumiyoshi T. 2006. Psychosis pathways converge via D2 (high) dopamine receptors. Synapse 60:319-346.
37. Selemon LD, Kleinman JE, Herman MM, Goldman-Rakic PS. 2002. Smaller frontal gray matter volume in postmortem schizophrenic brains. Am J Psychiatry 159:1983-1991.
38. Sesack SR, Deutch AY, Roth RH, Bunney BS. 1989. Topographical organization of the efferent projections of the medial prefrontal cortex in the rat: An anterograde tract-tracing study with Phaseolus vulgaris leucoagglutinin. J Comp Neurol 290:213-242.
39. Shenton ME, Dickey CC, Frumin M, McCarley RW. 2001. A review of MRI findings in schizophrenia. Schizophr Res 49:1-52.
40. Siever LJ, Davis KL. 2004. The pathophysiology of schizophrenia disorders: Perspectives from the spectrum. Am J Psychiatry 161:398-413.
41. Simon H, Taghzouti K, Gozlan H, Studler JM, Louilot A, Herve D, Glowinski J, Tassin JP, Le Moal M. 1988. Lesion of dopaminergic terminals in the amygdala produces enhanced locomotor response to d-amphetamine and opposite changes in dopaminergic activity in prefrontal cortex and nucleus accumbens. Brain Res 447:335-340.
42. Stevenson CW, Gratton A. 2004. Role of basolateral amygdala dopamine in modulating prepulse inhibition and latent inhibition in the rat. Psychopharmacology (Berl) 176:139-145.
43. Stevenson CW, Sullivan RM, Gratton A. 2003. Effects of basolateral amygdala dopamine depletion on the nucleus accumbens and medial prefrontal cortical dopamine responses to stress. Neuroscience 116:285-293.
44. Sumiyoshi T, Tsunoda M, Uehara T, Tanaka K, Itoh H, Sumiyoshi C, Kurachi M. 2004. Enhanced locomotor activity in rats with excitotoxic lesions of the entorhinal cortex, a neurodevelopmental animal model of schizophrenia: Behavioral and in vivo microdialysis studies. Neurosci Lett 364:124-129.
45. Sumiyoshi T, Seeman P, Uehara T, Itoh H, Tsunoda M, Kurachi M. 2005. Increased proportion of high-affinity dopamine D2 receptors in rats with excitotoxic damage of the entorhinal cortex, an animal model of schizophrenia. Brain Res Mol Brain Res 140:116-119.
46. Suzuki M, Zhou SY, Hagino H, Niu L, Takahashi T, Kawasaki Y, Matsui M, Seto H, Ono T, Kurachi M. 2005a. Morphological brain changes associated with Schneider's first-rank symptoms in schizophrenia: A MRI study. Psychol Med 35:549-560.
47. Suzuki M, Zhou SY, Takahashi T, Hagino H, Kawasaki Y, Niu L, Matsui M, Seto H, Kurachi M. 2005b. Differential contributions of prefrontal and temporolimbic pathology to mechanisms of psychosis. Brain 128(Part 9):2109-2122.
48. Swerdlow NR, Braff DL, Masten VL, Geyer MA. 1990a. Schizophrenic-like sensorimotor gating abnormalities in rats following dopamine infusion into the nucleus accumbens. Psychopharmacology (Berl) 101:414-420.
49. Swerdlow NR, Mansbach RS, Geyer MA, Pulvirenti L, Koob GF, Braff DL. 1990b. Amphetamine disruption of prepulse inhibition of acoustic startle is reversed by depletion of mesolimbic dopamine. Psychopharmacology (Berl) 100:413-416.
50. Swerdlow NR, Geyer MA, Braff DL. 2001. Neural circuit regulation of prepulse inhibition of startle in the rat: Current knowledge and future challenges. Psychopharmacology (Berl) 156:194-215.
51. Taber MT, Fibiger HC. 1995. Electrical stimulation of the prefrontal cortex increases dopamine release in the nucleus accumbens of the rat: Modulation by metabotropic glutamate receptors. J Neurosci 15(5 Part 2):3896-3904.
52. Tehovnik EJ, Sommer MA. 1997. Effective spread and timecourse of neural inactivation caused by lidocaine injection in monkey cerebral cortex. J Neurosci Methods 74:17-26.
53. Uehara T, Tanii Y, Sumiyoshi T, Kurachi M. 2000. Neonatal lesions of the left entorhinal cortex affect dopamine metabolism in the rat brain. Brain Res 860:77-86.
54. Uehara T, Sumiyoshi T, Itoh H, Kurachi M. 2003. Modulation of stress-induced dopamine release by excitotoxic damage of the entorhinal cortex in the rat. Brain Res 989:112-116.
55. Uehara T, Sumiyoshi T, Itoh H, Kurachi M. 2004. Inhibition of dopamine synthesis with α-methyl-p-tyrosine abolishes the enhancement of methamphetamine-induced extracellular dopamine levels in the amygdala of rats with excitotoxic lesions of the entorhinal cortex. Neurosci Lett 356:21-24.
56. Woods VE, Ettenberg A. 2004. Increased amphetamine-induced locomotion during inactivation of the basolateral amygdala. Behav Brain Res 149:33-39.
57. Zhang J, Forkstam C, Engel JA, Svensson L. 2000. Role of dopamine in prepulse inhibition of acoustic startle. Psychopharmacology (Berl) 149:181-188.
58. Zhou SY, Suzuki M, Hagino H, Takahashi T, Kawasaki Y, Matsui M, Seto H, Kurachi M. 2005. Volumetric analysis of sulci/gyri-defined in vivo frontal lobe regions in schizophrenia: Precentral gyrus, cingulate gyrus, and prefrontal region. Psychiatry Res 139:127-139.